To comply with the stringent requirements of ISO 14021 — and with defined criteria from TÜV Rheinland — the NexGen Press® has been externally audited to qualify for GEA’s newly introduced Add Better label*.
Sustainability in the pharmaceutical industry is no longer optional. Manufacturing drugs has a significant environmental footprint owing to resource consumption, waste generation and the emissions associated with production, packaging and distribution. The industry’s desire to embrace more planet-friendly practices will help the entire value chain to tackle pollution, climate change and resource depletion. GEA Pharma & Healthcare places a strong emphasis on sustainability and innovation to drive positive change within the organization and the sector as a whole.
Because GEA engineers wanted to get their evaluation processes right and let stakeholders know that transparency is an absolute priority, they decided to “put a label on it.” The Add Better label showcases GEA solutions that are significantly better than their predecessors when it comes to operational excellence and environmental impact. They represent the organization’s most resource-efficient solutions and demonstrate in a tangible way that a specific model is more cost-effective and planet-friendly to run than previous ones.
To examine the energy saving potential of the NexGen Press® 30, for example, the machine’s total electricity consumption was measured at the three-phase power supply inlet. Factors such as current, voltage and power were monitored as the press was operated at different speeds and compression forces, and compared with its forerunner, the PERFORMA P (base machine).
The results showed that the power output for the base machine (AC motor) was 5.5 kW whereas the NexGen Press® servomotor delivered 7 Kw with a 94% efficiency level at all speeds. The average power saving was calculated to be 21% compared with the base machine configuration.
Better Together: Innovation and Sustainability
The NexGen® Press range from GEA Pharma & Healthcare represents the future of tablet compression for the pharmaceutical industry. These performance-driven innovations facilitate machine selection and offer fast product changeovers with unrivaled containment and operational excellence.
Designed with digitalization and cost-efficiency in mind, key benefits include plug and play functionality for a wide range of applications, higher productivity levels and superior tablet quality. And, of course, like any GEA press, safety, robust functionality and reliability come as standard.
Modular by design, every NexGen Press® can be customized to fit specific applications — for now or the future — with predefined option packs. And, to expedite your journey to commercialization, GEA has extended its customer service and support offering to include NexGen® Press test machines at its centers of excellence.
Force Control and More
Made possible by GEA’s unique Air Compensator technology, every machine in the NexGen® Press range will be equipped with six compression modes. In addition to the industry standard force control, this unique device — fitted to the pre- and main compression stations — allows you to select five other tableting modes.
* The Add Better label relates to the serial product GEA NexGen Press® 30, released in August 2022.